SLT is a cost-effective, first-line glaucoma approach

Dr. Nate Radcliffe shares how Lumenis SLT is a cost-effective first-line approach for patients with glaucoma in this video from ASCRS San Diego.

Read Full Article

Nathan M. Radcliffe, MD

PB-00038930 Rev A